East Rutherford, NJ – February 2, 2018 – Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that fourth quarter and full year 2017 financial results will be released on Thursday, February 8, 2018 before the market opens.
The Company will host a conference call to discuss the financial results.
|Fourth Quarter 2017 Earnings Conference Call|
|When:||Thursday, February 8, 2018 at 8:30 a.m. Eastern Time|
|Dial-in:||1-888- 394-8218 for U.S.|
|1-323- 701-0226 for International|
|Dial-in Replay:||1-888- 203-1112 for U.S.|
|1-719- 457-0820 for International|
|Available through Thursday, February 15, 2018|
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals.
Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura
Investor Relations Associate
Tel: 201-804- 3037